Display options
Cite
Badruddoja MA, Pazzi M, Sanan A, et al. Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma. Cancer Chemother Pharmacol. 2018;81(1):223doi: 10.1007/s00280-017-3448-9.
Badruddoja, M. A., Pazzi, M., Sanan, A., Schroeder, K., Kuzma, K., Norton, T., Scully, T., Mahadevan, D., & Ahmadi, M. M. (2018). Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma. Cancer chemotherapy and pharmacology, 81(1), 223. https://doi.org/10.1007/s00280-017-3448-9
Badruddoja, Michael A, et al. "Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma." Cancer chemotherapy and pharmacology vol. 81,1 (2018): 223. doi: https://doi.org/10.1007/s00280-017-3448-9
Badruddoja MA, Pazzi M, Sanan A, Schroeder K, Kuzma K, Norton T, Scully T, Mahadevan D, Ahmadi MM. Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma. Cancer Chemother Pharmacol. 2018 Jan;81(1):223. doi: 10.1007/s00280-017-3448-9. PMID: 29034406.
Copy Download .nbib Format: NLM
Share it on

Cancer Chemother Pharmacol. 2018 Jan;81(1):223. doi: 10.1007/s00280-017-3448-9.

Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma.

Cancer chemotherapy and pharmacology

Michael A Badruddoja, Marjorie Pazzi, Abhay Sanan, Kurt Schroeder, Kevin Kuzma, Thomas Norton, Thomas Scully, Daruka Mahadevan, Michael Malek Ahmadi

Affiliations

  1. Center for Neurosciences, 2450 E River Rd, Tucson, AZ, 85718, USA. [email protected].
  2. Department of Radiation Oncology, Banner University Medical Center, 1501 N. Campbell Avenue, Tucson, AZ, 85724, USA. [email protected].
  3. Center for Neurosciences, 2450 E River Rd, Tucson, AZ, 85718, USA.
  4. Genentech, Inc., DNA Way, South San Francisco, CA, 94080, USA.
  5. Northwest Neurospecialists, 5860 N. La Cholla Blvd. Suite 100, Tucson, AZ, 85741, USA.
  6. University of Arizona Cancer Center, 1515 N. Campbell Avenue, Tucson, AZ, 85724, USA. [email protected].

PMID: 29034406 DOI: 10.1007/s00280-017-3448-9

[No abstract available.]

Publication Types